Page last updated: 2024-11-13

arabinogalactan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID24847856
MeSH IDM0047317

Synonyms (15)

Synonym
arabinogalactan ,
9036-66-2
galactoarabinan
d-galacto-l-arabinan
(+)-arabinogalactan
larch arabinogalactan
4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol
FT-0604415
SATHPVQTSSUFFW-UHFFFAOYSA-N
(+)-arabinogalactan from larch wood,
YL29121
E80438
3-o-methylpentopyranosyl-(1->6)-3-o-methylhexopyranosyl-(1->4)-2,6-anhydro-1-deoxyheptitol
DTXSID90864173
B1999-382163

Research Excerpts

Overview

Arabinogalactan (AG) is a high molecular weight polysaccharide composed of arabinose and galactose, which has good immunomodulatory, antioxidant and intestinal conditioning activities. It is an essential cell wall component in mycobacterial species, including the deadly human pathogen.

ExcerptReferenceRelevance
"Arabinogalactan (AG) is a high molecular weight polysaccharide composed of arabinose and galactose, which has good immunomodulatory, antioxidant and intestinal conditioning activities."( Arabinogalactan derived from Larix gmelinii (Rupr.) Kuzen. Alleviates cisplatin-induced acute intestinal injury in vitro and in vivo through IRE1α/JNK axis mediated apoptotic signaling pathways.
Gao, XF; Hou, JG; Hou, YY; Hu, JN; Li, W; Li, X; Wang, S; Wang, Z; Zhang, JJ; Zhang, JT, 2022
)
2.89
"Arabinogalactan (AG) is an essential cell wall component in mycobacterial species, including the deadly human pathogen "( Structure of the priming arabinosyltransferase AftA required for AG biosynthesis of
Batt, SM; Besra, GS; Da, L; Gong, Y; Gurcha, SS; Hao, Z; Lu, Q; Mu, N; Rao, Z; Veerapen, N; Wang, J; Wei, C; Wu, C; Yan, N; Yang, H; Yang, X; Zhang, L; Zhao, Y, 2023
)
2.35
"Arabinogalactan (AG) is a hydrophilic polysaccharide with highly branched long chains."( Conjugation of haloalkane dehalogenase DhaA with arabinogalactan to increase its stability.
Guo, X; Hu, T; Shen, L; Wang, M; Yu, W; Zheng, H; Zhong, J, 2021
)
1.6
"Arabinogalactans are a source of dietary fiber with health benefits. "( Characterization of arabinogalactans from Larix principis-rupprechtii and their effects on NO production by macrophages.
Fan, Y; Huang, C; Jiang, M; Lai, C; Tang, S; Yong, Q, 2018
)
2.25
"Arabinogalactan (AG) is a health-promoting substance with numerous biological activities."( Conjugation of staphylokinase with the arabinogalactan-PEG conjugate: Study on the immunogenicity, in vitro bioactivity and pharmacokinetics.
Hu, C; Hu, T; Qi, F; Qi, J; Shen, L; Yu, W, 2019
)
1.5
"Arabinogalactan is a naturally-occurring, densely branched, polysaccharide mainly made-up of galactose and arabinose with variable amounts of uronic acids, which received attention for several industrial and biomedical applications. "( Interaction of arabinogalactan with mucins.
Balestri, F; Boldrini, E; Cappiello, M; Del-Corso, A; Falcone, G; Gini, F; Moschini, R; Mura, U, 2014
)
2.2
"Arabinogalactan is a polysaccharide isolated from the roots of the medicinal plant Withania somnifera L. "( Antitussive activity of Withania somnifera and opioid receptors.
Flešková, D; Fraňová, S; Nosálová, G; Ondrejka, I; Ray, B; Sivová, V, 2015
)
1.86
"Arabinogalactan (AG) is a biocompatible polysaccharide that can increase splenocyte proliferation and stimulate macrophages."( Potent Antigen-Adjuvant Delivery System by Conjugation of Mycobacterium tuberculosis Ag85B-HspX Fusion Protein with Arabinogalactan-Poly(I:C) Conjugate.
Hu, T; Huang, Q; Yu, W, 2016
)
1.37
"Arabinogalactan is a recognized soluble fiber and is currently being used in products because it is not viscous, is easily incorporated into foods and beverages, and is well accepted by consumers."( No long-term benefits of supplementation with arabinogalactan on serum lipids and glucose.
Marett, R; Slavin, JL, 2004
)
1.3
"Arabinogalactan (AG) is a non-digestible soluble dietary fiber that resists hydrolytic enzyme action and enters the large bowel intact where it is fermented by resident microflora. "( Effects of dietary arabinogalactan on gastrointestinal and blood parameters in healthy human subjects.
Feirtag, J; Robinson, RR; Slavin, JL, 2001
)
2.08
"Arabinogalactan is a unique dietary fiber that affects the digestive physiology and immunological characteristics of dogs."( Oral administration of arabinogalactan affects immune status and fecal microbial populations in dogs.
Fahey, GC; Flickinger, EA; Grieshop, CM, 2002
)
1.35

Effects

ExcerptReferenceRelevance
"Arabinogalactan proteins have been shown to be involved in the cell elongation process."( Characterization of a pollen-preferential gene OSIAGP from rice (Oryza sativa L. subspecies indica) coding for an arabinogalactan protein homologue, and analysis of its promoter activity during pollen development and pollen tube growth.
Anand, S; Tyagi, AK, 2010
)
1.29

Actions

ExcerptReferenceRelevance
"Arabinogalactan did not activate B cells and did not induce T cells to produce interleukin-2, interferon-beta 2, or interferon-gamma, but it did induce a slight increase in T-cell proliferation."( Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea.
Gifford, GE; Lohmann-Matthes, ML; Luettig, B; Steinmüller, C; Wagner, H, 1989
)
1.26

Treatment

Arabinogalactan treatments included a high (1.65 g/d) and low (0.55 g/D) dose of AG100, AG1000 or AG3000 provided via gelatin capsules. Treatment with arabinogAlactan reduced the amount of liver metastases and prolonged the survival times of the animals.

ExcerptReferenceRelevance
"Arabinogalactan treatments included a high (1.65 g/d) and low (0.55 g/d) dose of AG100, AG1000 or AG3000 provided via gelatin capsules."( Oral administration of arabinogalactan affects immune status and fecal microbial populations in dogs.
Fahey, GC; Flickinger, EA; Grieshop, CM, 2002
)
1.35
"Treatment with arabinogalactan reduced the amount of liver metastases and prolonged the survival times of the animals in both studies."( Arabinogalactan blockade of experimental metastases to liver by murine hepatoma.
Hagmar, B; Ryd, W; Skomedal, H, 1991
)
2.06

Toxicity

ExcerptReferenceRelevance
" In 1 baboon, melibiose and arabinogalactan infusion delayed vascular rejection of a pig cardiac xenograft from 10 min to about 12 hr, at which time the baboon died from the toxic effects of the carbohydrate infusion."( Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts.
Cooper, DK; Koren, E; Kosanke, S; Martin, M; Neethling, FA; Niekrasz, M; Oriol, R; Richards, SV; Ye, Y, 1994
)
0.58
" Therefore, it is concluded that LL-4218 did not produce any significant toxic effect on reproduction and developmental parameters of rats and NOAEL for reproductive and developmental toxicity studies in rats was 1000 mg kg(-1)."( Reproductive and developmental toxicity evaluation of a purified Arabinogalactan-Protein (AGP) composition in Wistar rats.
Arora, S; Bhatnagar, U; Singh, M; Tamboli, S; Vishwase, G, 2010
)
0.6
"BAK showed toxic effects on corneal epithelium in all experiments."( Arabinogalactan as active compound in the management of corneal wounds: in vitro toxicity and in vivo investigations on rabbits.
Boldrini, E; Burgalassi, S; Chetoni, P; Fabiani, O; Falcone, G; Lenzi, C; Monti, D; Nicosia, N; Pirone, A, 2011
)
1.81
"Our results suggest that AG can interact with corneal epithelial cells without any toxic side effect; moreover, it proved to stimulate cell proliferation, thus promoting tissue re-epithelialization and reorganization just 48 hr post-wounding."( Arabinogalactan as active compound in the management of corneal wounds: in vitro toxicity and in vivo investigations on rabbits.
Boldrini, E; Burgalassi, S; Chetoni, P; Fabiani, O; Falcone, G; Lenzi, C; Monti, D; Nicosia, N; Pirone, A, 2011
)
1.81
"The main undesirable side effect of the aspirin is the damage to the gastrointestinal mucosa, leading to the formation of erosions, peptic ulcers, and as a result, bleeding."( Improving the Efficiency and Safety of Aspirin by Complexation with the Natural Polysaccharide Arabinogalactan.
Borisov, SA; Chistyachenko, YS; Dushkin, AV; Khvostov, MV; Polyakov, NE; Tolstikova, TG; Zhukova, NA, 2016
)
0.65
" Long-term introduction of the complex at doses of 250 and 500 mg/kg was safe for gastric mucosa, while ASA at the dose of 50 mg/kg showed a strong gastric mucosal damage."( Improving the Efficiency and Safety of Aspirin by Complexation with the Natural Polysaccharide Arabinogalactan.
Borisov, SA; Chistyachenko, YS; Dushkin, AV; Khvostov, MV; Polyakov, NE; Tolstikova, TG; Zhukova, NA, 2016
)
0.65

Bioavailability

ExcerptReferenceRelevance
"Complexation of known drugs with carbohydrate-containing plant metabolites is a promising way to synthesize new drugs that does not only save pharmacological properties of initial agent but also acquire a number of advantageous features such as increased water solubility, bioavailability and decreased toxicity."( The complexes of drugs with carbohydrate-containing plant metabolites as pharmacologically promising agents.
Bryzgalov, AO; Khvostov, MV; Tolstikova, TG, 2009
)
0.35
"Since carotenoids are highly hydrophobic, air- and light-sensitive hydrocarbon compounds, developing methods for increasing their bioavailability and stability towards irradiation and reactive oxygen species is an important goal."( Water soluble biocompatible vesicles based on polysaccharides and oligosaccharides inclusion complexes for carotenoid delivery.
Kispert, LD; Polyakov, NE, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
" After cessation of dosing with the conjugate, serum viral DNA levels remained depressed for 42 days."( Conjugation of adenine arabinoside 5'-monophosphate to arabinogalactan: synthesis, characterization, and antiviral activity.
Enriquez, PM; Josephson, L; Jung, C; Tennant, BC,
)
0.38
" Rats were dosed daily orally with vehicle, Ambrotose or Advanced Ambrotose."( Plant-derived polysaccharide supplements inhibit dextran sulfate sodium-induced colitis in the rat.
Boulet, J; Grover, G; Jacoby, HI; Koetzner, L, 2010
)
0.36
" In the second (main) group, this treatment is supplemented with the use of Fibraxin, at a dosage of 6g 1 time per day, the observation period is 4 weeks."( [Prospects for stimulation in early rehabilitation of patients and restoration of bowel function after proctological operations].
Groshilin, VS; Lukash, YV; Martynov, DV; Shvetsov, VK; Tsygankov, PV, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Items)

ItemProcessFrequency
Snackscore-ingredient4

Research

Studies (651)

TimeframeStudies, This Drug (%)All Drugs %
pre-199041 (6.30)18.7374
1990's78 (11.98)18.2507
2000's177 (27.19)29.6817
2010's259 (39.78)24.3611
2020's96 (14.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.98 (24.57)
Research Supply Index6.54 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index98.80 (26.88)
Search Engine Supply Index3.97 (0.95)

This Compound (33.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials10 (1.47%)5.53%
Reviews45 (6.64%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other623 (91.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]